LAWRENCE, Mass., April 12, 2016 /PRNewswire/ -- NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc., today announced the opening of two new dialysis centers in Baltimore, Maryland. The centers, located in Linthicum Heights (Baltimore West) and Timonium (Baltimore North), offer patients with kidney failure personalized therapy options designed to give patients more freedom, flexibility, and control over their treatments.
Both centers offer in-center hemodialysis, home hemodialysis (HHD), home nocturnal hemodialysis (HNHD), peritoneal dialysis (PD), and short-term respite care. Each center provides personalized training for home dialysis, along with transplant and travel assistance, and the support of a social worker and dietitian.
"Having spent nearly three decades taking care of patients with kidney disease, I understand that every person has unique needs," said Dr. Kulwant Singh Modi, Medical Director at NxStage Kidney Care Baltimore West. "I am proud to work with a team that offers a variety of therapy options, giving patients access to the treatment option that works best for them."
Local NxStage Kidney Care Locations:
10003 Derekwood Lane, Ste 100
Lanham, MD 20706
Medical Director: Ashté Collins, MD
"We remain committed to providing patients access to high quality care and dialysis treatment options that meet their health and lifestyle needs," said Robert Brown, President of NxStage Kidney Care. For more information about NxStage Kidney Care and the therapy options offered please visit www.nxstagekidneycare.com.
About NxStage Kidney Care
NxStage Kidney Care, Inc., a subsidiary of NxStage Medical, Inc. (Nasdaq: NXTM), is innovating a dialysis care model that is intended to support and encourage patient-centered care and provide enhanced access to the life-changing benefits of home therapy as well as flexible in-center options. By leveraging NxStage's home leadership and the innovative technology of its System One, NxStage Kidney Care is committed to helping patients take control of their dialysis and to allowing physicians the flexibility to prescribe what is truly best for their patients. For more information, please visit www.nxstagekidneycare.com or call (866) 694-2707.
About NxStage Medical
NxStage Medical, Inc. (Nasdaq: NXTM) is a leading medical technology company, headquartered in Lawrence, Massachusetts, USA, that develops, manufactures and markets innovative products for the treatment of end-stage renal disease (ESRD) and acute kidney failure. NxStage also has established a small number of dialysis clinics committed to the development of innovative care delivery models for patients with ESRD. For more information on NxStage and its products and services, please visit the Company's websites at www.nxstage.com and www.nxstagekidneycare.com.
This release contains "forward-looking statements" within the meaning of the Private Securities Litigation Reform Act of 1995. All statements contained in this release that are not clearly historical in nature are forward-looking, and the words "anticipate," "believe," "expect," "estimate," "plan," and similar expressions are generally intended to identify forward-looking statements. Actual results may differ materially from those indicated by these forward-looking statements as a result of various important factors including those that are discussed in NxStage's filings with the Securities and Exchange Commission, including the Annual Report on Form 10-K for the year ended December 31, 2015. NxStage is under no obligation to (and expressly disclaims any such obligation to) update or alter its forward-looking statements, whether as a result of new information, future events or otherwise.
Kristen K. Sheppard, Esq.
SOURCE NxStage Kidney Care, Inc.